Christian O. Henry M.B.A. Net Worth

The estimated Net Worth of Christian O Henry is at least $25 million dollars as of 4 March 2024. Mr Henry owns over 14,177 units of Pacific Biosciences of California Inc stock worth over $4,362,406 and over the last 19 years he sold PACB stock worth over $19,866,416. In addition, he makes $772,454 as Pres et CEO & Director at Pacific Biosciences of California Inc.

Mr A PACB stock SEC Form 4 insiders trading

Mr has made over 99 trades of the Pacific Biosciences of California Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he sold 14,177 units of PACB stock worth $69,042 on 4 March 2024.

The largest trade he's ever made was selling 96,844 units of Pacific Biosciences of California Inc stock on 18 September 2023 worth over $980,061. On average, Mr trades about 8,960 units every 42 days since 2005. As of 4 March 2024 he still owns at least 2,596,670 units of Pacific Biosciences of California Inc stock.

You can see the complete history of Mr Henry stock trades at the bottom of the page.

Mr. Christian O. Henry M.B.A. biography

Christian O. Henry M.B.A. is the Pres, CEO & Director at Pacific Biosciences of California Inc.

What is the salary of Mr A?

As the Pres et CEO & Director of Pacific Biosciences of California Inc, the total compensation of Mr A at Pacific Biosciences of California Inc is $772,454. There are 1 executives at Pacific Biosciences of California Inc getting paid more, with Michael Hunkapiller having the highest compensation of $859,188.

How old is Mr A?

Mr A is 53, he's been the Pres et CEO & Director of Pacific Biosciences of California Inc since . There are 9 older and 8 younger executives at Pacific Biosciences of California Inc. The oldest executive at Pacific Biosciences of California Inc is Lucy Shapiro, 79, who is the Independent Director.

What's Mr A's mailing address?

Christian's mailing address filed with the SEC is C/O WAVE LIFE SCIENCES LTD.,, 733 CONCORD AVE., CAMBRIDGE, MA, 02138.

Insiders trading at Pacific Biosciences of California Inc

Over the last 14 years, insiders at Pacific Biosciences of California Inc have traded over $95,441,111 worth of Pacific Biosciences of California Inc stock and bought 2,252,330 units worth $6,097,136 . The most active insiders traders include Michael Hunkapiller, John F Milligan et Christian O Henry. On average, Pacific Biosciences of California Inc executives and independent directors trade stock every 44 days with the average trade being worth of $202,112. The most recent stock trade was executed by Jeff Eidel on 19 August 2024, trading 26,760 units of PACB stock currently worth $42,548.

What does Pacific Biosciences of California Inc do?

pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.

Complete history of Mr Henry stock trades at Illumina Inc, Pacific Biosciences of California Inc et Wave Life Sciences

Pacific Biosciences of California Inc executives and stock owners

Pacific Biosciences of California Inc executives and other stock owners filed with the SEC include:

• Michael Hunkapiller,
  Director
• Christian O. Henry M.B.A.,
  Pres, CEO & Director
• Susan G. Kim,
  Chief Financial Officer
• Dr. Denis Zaccarin Ph.D.,
  Sr. VP of R&D
• William Ericson,
  Independent Director
• Randall Livingston,
  Independent Director
• Marshall Mohr,
  Independent Director
• John Milligan,
  Independent Chairman of the Board
• Lucy Shapiro,
  Independent Director
• Kathy Ordonez,
  Director
• Christian Henry,
  President, Chief Executive Officer, Director
• David Botstein,
  Independent Director
• Susan Kim,
  Chief Principal Officer, Chief Accounting Officer
• Eric Schaefer,
  Chief Accounting Officer, Vice President
• Denis Zaccarin,
  Vice President - Semiconductor Integration Devices
• Chris Seipert,
  Vice President, Sales, Service & Support, EMEA and America
• Kathleen Lynch J.D.,
  Head of Global Gov. Affairs & Corp. Communications
• Michele Farmer CPA,
  VP & Chief Accounting Officer
• Kathleen Lynch,
  Head of Global Gov. Affairs & Corp. Communications
• Brett Atkins J.D., Ph.D.,
  Gen. Counsel & Corp. Sec.
• Trevin Rard,
  Head of Investor Relations
• Dr. Jonas Korlach Ph.D.,
  Chief Scientific Officer
• Michele Farmer,
  VP & Chief Accounting Officer
• Mark Van Oene,
  Chief Operating Officer
• Dr. Stephen Turner,
  Co-Founder & CTO
• James Michael Phillips,
  SVP, Research & Development
• Susan K Barnes,
  EVP, CFO and PAO
• Kevin P Corcoran,
  SVP, Market Development
• Brook H Byers,
  Director
• Jeff Eidel,
  See Remarks
• Brian B Dow,
  VP and PAO
• Michael Glynn,
  Chief Commercial Officer
• David B Singer,
  Director
• Susan E Siegel,
  Director
• Hugh C Martin,
  Chairman, CEO & President
• Stephen W Turner,
  VP & Chief Technology Officer
• Hannah Valantine,
  Director
• Oene Mark Van,
  See Remarks
• Peter Fromen,
  See Remarks
• Michele Farmer,
  See Remarks
• David W Meline,
  Director